[Form 4] InfuSystem Holdings, Inc Insider Trading Activity

Rhea-AI Filing Summary

Insider filing for Carrie Lachance, President and CEO of InfuSystem Holdings (INFU). On 09/23/2025, 50,000 performance-based restricted stock units granted May 16, 2025, vested and were settled into common stock. The issuer withheld 19,675 shares to cover tax withholding at an indicated value of $10.22 per share, leaving the reporting person with 232,174 shares beneficially owned after the transactions. The Form 4 shows the reporting person held 201,849 shares before the vesting, which increased to 251,849 upon settlement then decreased due to withholding. This filing documents routine equity compensation vesting and related tax withholding by an executive who is also a director.

Positive

• Vesting of 50,000 performance-based RSUs demonstrates achievement of performance conditions and retention incentives for the CEO.
• Net beneficial ownership increased from 201,849 to 232,174 shares after settlement and withholding, maintaining insider alignment with shareholders.

Negative

• 19,675 shares were withheld for taxes, reducing the net shares delivered to the reporting person.
• Transaction was filed as a routine compensation settlement, so it does not provide new open-market buying that might signal additional conviction.

Insights

Financial Analyst

TL;DR: Routine executive equity vesting; modest net increase in ownership after tax withholding.

The filing documents the vesting of 50,000 performance-based RSUs and the subsequent withholding of 19,675 shares to satisfy taxes at a reported price of $10.22. The net result is an increase from 201,849 to 232,174 shares beneficially owned, indicating continued executive equity exposure to company performance. This is a standard compensation settlement rather than an open-market purchase or sale, so immediate market liquidity impact is limited. Investors should note the transaction type and that the reporting person remains a substantial insider.

Corporate Governance Expert

TL;DR: Standard executive compensation mechanics; shows alignment via continued share ownership.

The report signals fulfillment of performance conditions tied to RSUs granted May 16, 2025, followed by automatic tax withholding. As both an officer and director, the reporting person retains a significant position post-settlement, which supports alignment with shareholder interests. There are no indications of unusual timing, related-party transfers, or discretionary sales in this filing. This is a routine disclosure under Section 16.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Lachance Carrie

(Last) (First) (Middle)

C/O INFUSYSTEM HOLDINGS, INC.

3851 WEST HAMLIN ROAD

(Street)

ROCHESTER HILLS MI 48309

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
InfuSystem Holdings, Inc [ INFU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
09/23/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								201,849	D
Common Stock	09/23/2025		A(1)		50,000	A	$0	251,849	D
Common Stock	09/23/2025		F(2)		19,675	D	$10.22	232,174	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On September 23, 2025, 50,000 performance-based restricted stock units, granted on May 16, 2025, vested

2. Represents the withholding of the Issuer's common stock for the tax liability associated with the vesting and settlement of the common stock issued on May 16, 2025

Remarks:

	/s/ Kevin Whitman, Attorney-in-Fact for Carrie Lachance	09/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed the Form 4 for INFU and what is their role?

The Form 4 was filed for Carrie Lachance, who is listed as President and CEO and a Director of InfuSystem Holdings.

What securities transaction occurred on 09/23/2025 for INFU?

On 09/23/2025, 50,000 performance-based RSUs vested and were settled into common stock; 19,675 shares were withheld for tax withholding.

How many INFU shares does the reporting person beneficially own after the transaction?

After the transactions and tax withholding, the reporting person beneficially owns 232,174 shares.

What was the price indicated for the withheld shares?

The filing indicates a price of $10.22 associated with the withholding of shares for tax liability.

Was this Form 4 a purchase, sale, or compensation settlement?

This Form 4 reflects a compensation settlement (vesting and settlement of performance-based RSUs) and related tax withholding, not an open-market purchase or sale.